GlassScriptPhysician profile
Craig N Moss
NPI 1568414126
$7,824.74
in general payments reported to CMS, 2019-2025
64 companies · $835 in 2025
The $835 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,042 · 2020: $696 · 2021: $905 · 2022: $1,078 · 2023: $1,097 · 2024: $1,172 · 2025: $835.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,089 · Consulting Fee: $14.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,089.03 |
| Consulting Fee | $14.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $791.76 | 2019-2025 | Evenity, Prolia, Repatha |
| Novo Nordisk INC | $689.43 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $666.03 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $653.49 | 2019-2025 | Farxiga, Saphnelo, Airsupra |
| Glaxosmithkline, LLC. | $601.33 | 2019-2024 | Shingrix, Arexvy, Nucala |
| Merck Sharp & Dohme LLC | $443.53 | 2019-2025 | Pifeltro, Delstrigo, Dificid |
| Novartis Pharmaceuticals Corporation | $383.18 | 2019-2024 | |
| Lilly USA, LLC | $332.39 | 2019-2025 | Jardiance, Lyumjev, Baqsimi |
| Janssen Pharmaceuticals, INC | $313.04 | 2019-2022 | |
| Pfizer INC. | $292.50 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $278.31 | 2021-2025 | |
| Allergan, INC. | $195.22 | 2019-2020 | |
| Viiv Healthcare Company | $185.32 | 2020-2025 | Rukobia, Apretude |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $172.61 | 2019-2024 | Xifaxan |
| Exact Sciences Corporation | $136.73 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 64 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.